Related references
Note: Only part of the references are listed.The immunomodulatory drug lenalidomide restores a vitamin D sensitive phenotype to the vitamin D resistant breast cancer cell line MDA-MB-231 through inhibition of BCL-2: potential for breast cancer therapeutics
Carole Brosseau et al.
APOPTOSIS (2012)
Vitamin D and cancer: a review of molecular mechanisms
James C. Fleet et al.
BIOCHEMICAL JOURNAL (2012)
The Intrinsic Apoptosis Pathways as a Target in Anticancer Therapy
Verena Jendrossek
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Vitamin D-Related Genetic Variation, Plasma Vitamin D, and Risk of Lethal Prostate Cancer: A Prospective Nested Case-Control Study
Irene M. Shui et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Suppression of Prostate Cancer Cell Rolling and Adhesion to Endothelium by 1α,25-Dihydroxyvitamin D3
Jong-Wei Hsu et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D
Aruna V. Krishnan et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)2vitarnin D3: Genomic and non-genomic mechanisms
Mark R. Haussler et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Hepatocellular carcinoma and vitamin D: A review
Kun-Chun Chiang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Substitution at carbon 2 of 19-nor-1α,25-dihydroxyvitamin D3 with 3-hydroxypropyl group generates an analogue with enhanced chemotherapeutic potency in PC-3 prostate cancer cells
Diego Iglesias-Gato et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Nuclear hormone 1α,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy
Sami Heikkinen et al.
NUCLEIC ACIDS RESEARCH (2011)
PHYSIOLOGICAL RELEVANCE OF CELL CYCLE KINASES
Marcos Malumbres
PHYSIOLOGICAL REVIEWS (2011)
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells
Kun-Chun Chiang et al.
STEROIDS (2011)
Pathways mediating VEGF-independent tumor angiogenesis
Napoleone Ferrara
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Nuclear Targeting of Cyclin-Dependent Kinase 2 Reveals Essential Roles of Cyclin-Dependent Kinase 2 Localization and Cyclin E in Vitamin D-Mediated Growth Inhibition
Omar Flores et al.
ENDOCRINOLOGY (2010)
A ChIP-seq defined genome-wide map of vitamin D receptor binding: Associations with disease and evolution
Sreeram V. Ramagopalan et al.
GENOME RESEARCH (2010)
Update in Vitamin D
John S. Adams et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Photoprotection by 1α,25-dihydroxyvitamin D and analogs: Further studies on mechanisms and implications for UV-damage
R. S. Mason et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2010)
EB1089 Induces Skp2-Dependent p27 Accumulation, Leading to Cell Growth Inhibition and Cell Cycle G1 Phase Arrest in Human Hepatoma Cells
Wenjing Luo et al.
CANCER INVESTIGATION (2009)
Nonclassic Actions of Vitamin D
Daniel Bikle
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells
Vandanajay Bhatia et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Novel synthesis of 1α,25-dihydroxy-19-norvitamin D from 25-hydroxyvitamin D
Asako Toyoda et al.
TETRAHEDRON (2009)
2-Substituted-16-ene-22-thia-1α, 25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs:: Synthesis, biological evaluation, and crystal structure
Masato Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
19-nor-1 alpha,25-dihydroxyvitamin D-2 (Paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo
Gary G. Schwartz et al.
CANCER BIOLOGY & THERAPY (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
Yihai Cao et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Vitamin D analogs: Therapeutic applications and mechanisms for selectivity
Alex J. Brown et al.
MOLECULAR ASPECTS OF MEDICINE (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Structural refinement of seco-steroidal skeleton and the biological activity through nuclear receptors
Atsushi Kittaka
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2008)
Vitamin D receptor-dependent inhibition of mammary tumor growth by EB1089 and ultraviolet radiation in vivo
Meggan E. Valrance et al.
ENDOCRINOLOGY (2007)
Evaluation of C-2-substituted 19-nor-1α,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer
T. C. Chen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Creative synthesis of novel vitamin D analogs for health and disease
Atsushi Kittaka et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2007)
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Kristin K. Deeb et al.
NATURE REVIEWS CANCER (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Probing a water channel near the A-ring of receptor-bound 1α,25-dihydroxyvitamin D3 with selected 2α-substituted analogues
Shinji Hourai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
New 2-alkylidene 1α,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity:: Synthesis and biological evaluation of 2-(3′-alkoxypropylidene) and 2-(3-hydroxypropylidene) derivatives
Agnieszka Glebocka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Earlier onset of tumoral anglogenesis in matrix metalloproteinase-19-deficient mice
Maud Jost et al.
CANCER RESEARCH (2006)
Regulation of the human p21((waf1/cip1)) gene promoter via multiple binding sites for p53 and the vitamin D-3 receptor
A Saramaki et al.
NUCLEIC ACIDS RESEARCH (2006)
Differential antiproliferative effects of calcitriol on tumor-derived and matrigel-derived endothelial cells
Ivy Chung et al.
CANCER RESEARCH (2006)
Recent results on A-ring modification of 1 alpha,25-dihydroxyvitamin D-3: Design and synthesis of VDR-agonists and antagonists with high biological activity
Nozomi Saito et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
1 alpha,25-dihydroxyvitamin D-3 inhibits prostate cancer cell invasion via modulation of selective proteases
BY Bao et al.
CARCINOGENESIS (2006)
Phase I/II study of 19-nor-1α-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer
GG Schwartz et al.
CLINICAL CANCER RESEARCH (2005)
Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer
J Moreno et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
22-oxa-1α,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer
K Nakagawa et al.
CARCINOGENESIS (2005)
Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction
G Eelen et al.
MOLECULAR PHARMACOLOGY (2005)
1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage
P De Haes et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2005)
Apoptosis pathways in cancer and cancer therapy
KM Debatin
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Rapid modulation of osteoblast ion channel responses by 1α,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor
LP Zanello et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Vitamin D3 modulated gene expression patterns in human primary normal and cancer prostate cells
M Guzey et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase
F Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Vascular endothelial growth factor: Basic science and clinical progress
N Ferrara
ENDOCRINE REVIEWS (2004)
The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro
JA Huhtakangas et al.
MOLECULAR ENDOCRINOLOGY (2004)
Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays
AV Krishnan et al.
PROSTATE (2004)
Apoptosis in lymphoid organs of pigs naturally infected by porcine circovirus type 2
AR Resendes et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis
DM Peehl et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
1,25-dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway
G Wong et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm
ES Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Vitamin D and prostate cancer prevention and treatment
TC Chen et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2003)
Efficient synthesis of 2-modified 1α,25-dihydroxy-19-norvitamin D3 with Julia Olefination:: High potency in induction of differentiation on HL-60 cells
K Ono et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma
K Dalhoff et al.
BRITISH JOURNAL OF CANCER (2003)
Vitamin D receptor is not required for the rapid actions of 1,25-dihydroxyvitamin D3 to increase intracellular calcium and activate protein kinase C in mouse osteoblasts
RK Wali et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice
GM Zinser et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2003)
Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts
WR Duan et al.
JOURNAL OF PATHOLOGY (2003)
p53 is required for 1,25-dihydroxyvitamin D-3-induced G(0) arrest but is not required for G(1) accumulation or apoptosis of LNCaP prostate cancer cells
TC Polek et al.
ENDOCRINOLOGY (2003)
2-ethyl and 2-ethylidene analogues of 1α,25-dihydroxy-19-norvitamin D3:: Synthesis, conformational analysis, biological activities, and docking to the modeled rVDR ligand binding domain
RR Sicinski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Improved detection of apoptotic cells in archival paraffin sections: Immunohistochemistry using antibodies to cleaved caspase 3
AM Gown et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Vitamin D-mediated growth inhibition of an androgen-ablated LNCaP cell line model of human prostate cancer
ES Yang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Efficient and versatile synthesis of novel 2α-substituted 1α,25-dihydroxyvitamin D3 analogues and their docking to vitamin D receptors
Y Suhara et al.
JOURNAL OF ORGANIC CHEMISTRY (2001)
Novel synthetic approach to 19-nor-1α,25-dihydroxyvitamin D3 and its derivatives by Suzuki-Miyaura coupling in solution and on solid support
T Hanazawa et al.
ORGANIC LETTERS (2001)
Inhibitory effects of 1α,25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery
SS Jensen et al.
MOLECULAR ENDOCRINOLOGY (2001)
1α,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2
J Akhter et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY (2001)
Regulation of gene expression by 1α,25-dihydroxyvitamin D3 and its analog EB1089 under growth-inhibitory conditions in squamous carcinoma cells
N Akutsu et al.
MOLECULAR ENDOCRINOLOGY (2001)
The vitamin D3 analog, ILX-23-7553, enhances the response to Adriamycin and irradiation in MCF-7 breast tumor cells
M Chaudhry et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
1α,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo
DJ Mantell et al.
CIRCULATION RESEARCH (2000)
VDR-Alien:: a novel, DNA-selective vitamin D3 receptor-corepressor partnership
P Polly et al.
FASEB JOURNAL (2000)
Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of bcl-2
SE Blutt et al.
ENDOCRINOLOGY (2000)
Share Paper
